Icotinib Hydrochloride

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.

Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.

BPI-2009H

Others

Other Targets

EGFR; EGFR mutants

Cancer

——

1204313-51-8

427.88

C22H22ClN3O4

98%

DMSO : 25 mg/mL. 58.43 mM;

C#Cc1cc(ccc1)Nc1ncnc2cc3OCCOCCOCCOc3cc12.Cl

——

(-20℃)

With Ice Pack

≥ 2 years